The protein programmers
Fighting cancer also prompted the founding of Mainz-based BioNTech, widely known for its rapid development of a Covid 19 vaccine in 2020. „Our founders Özlem Türeci and Ugur Sahin worked as oncologists, and they were just tired of just managing death instead of really saving patients,“ says Dr. Sylke Maas, responsible for investor relations and strategy. BioNTech’s research into the molecular basis of the immune system with new technologies should deliver therapies not only against cancer, but also against infectious and autoimmune diseases, which can then also be rapidly disseminated through global partnerships.